secwatch.observer — SEC 8-K summary
======================================

Issuer:     2seventy bio, Inc. (—)
CIK:        0001860782
Form:       8-K/A
Filed at:   2024-02-02T23:59:59+00:00
Accession:  0001860782-24-000009
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

2seventy bio appoints William Baird as CEO and Victoria Eatwell as CFO effective at closing
--------------------------------------------------------------------------------

- William D. Baird III appointed CEO; previously COO and CFO; base salary $575k, target bonus 55%.
- Baird receives initial equity grant: option for 112,500 shares and RSUs for 56,250 shares.
- Victoria Eatwell appointed CFO; previously SVP of Finance; base salary $425k, target bonus 40%.
- Eatwell receives initial equity grant: option for 85,000 shares and RSUs for 42,500 shares.
- Severance: Baird gets 1.5x base salary on change-in-control termination; Eatwell gets 1x base.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860782/000186078224000009/0001860782-24-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860782/000186078224000009/tvst-20240129.htm
  HTML page:      https://secwatch.observer/filing/0001860782-24-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer